Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM IN RELIEVING, INTERRUPTING, AND PREVENTING CHRONIC MIGRAINE (RELIEV-CM2)

NCT06167655 is registered in ClinicalTrials.gov with ShiraTronics as lead sponsor.

NCT NCT06167655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06167655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM IN RELIEVING, INTERRUPTING, AND PREVENTING CHRONIC MIGRAINE (RELIEV-CM2)
Lead sponsor
ShiraTronics
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 29, 2024
Completion date
May 31, 2031
Enrollment
250 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

headache migraine chronic